Romilast B (5+5) Tablet

Romilast B (5+5) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Ranbaxy Laboratories Ltd.,. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Bambuterol, Montelukast. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 102.15 (arround $1.4301 US Dollar)
Generic (Salt) Combination :(Bambuterol+ Montelukast)
Pharma Company :Ranbaxy Laboratories Ltd.,
Brand Label :Romilast B (5+5)
Preparation Type :Tablet
Single Dose :1 Tablet
Composition (Fixed-Dose Combination) :
  • Bambuterol-5 mg
  • Montelukast-5 mg
Pack Size/Qty/Vol :10 Tablet
Price Unit :Rs 10.22 INR (arround $0.14308 US Dollar)
Price Pack :Rs 102.15 INR (arround $1.4301 US Dollar)

Drug details for Romilast B (5+5)

Usage: Why is this medication prescribed?

The main active ingredients or salts in Romilast B (5+5) are :

  • Bambuterol-5 mg
  • Montelukast-5 mg

Bambuterol
Indication (Prescribed for or used as): Maintenance treatment of bronchial asthma, nocturnal asthma or COPD.

For more details on Bambuterol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Bambuterol..

Montelukast
Indication (Prescribed for or used as): Montelukast is used to prevent wheezing, difficulty breathing, chest tightness, and coughing caused by asthma. Montelukast is also used to prevent bronchospasm (breathing difficulties) during exercise. Montelukast is also used to treat the symptoms of seasonal (occurs only at certain times of the year), and perennial (occurs all year round) allergic rhinitis (a condition associated with sneezing and stuffy, runny or itchy nose). Montelukast is in a class of medications called leukotriene receptor antagonists (LTRAs). It works by blocking the action of substances in the body that cause the symptoms of asthma and allergic rhinitis.

Chronic asthma. Seasonal allergic rhinitis. Perennial allergic rhinitis. Prophylaxis of exercise-induced asthma.

For more details on Montelukast, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Montelukast..

Romilast B (5+5) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :

There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Romilast B (5+5), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Bambuterol-5 mg Montelukast-5 mg).
Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.

BrandPrice (Rs.)BrandPrice (Rs.)

Search Drug Brands alphabetically